Legal 500
Log in or register
  • Rankings

    • Jurisdictions
    • Submissions
    • Future Lawyers
  • Firms & Lawyers

    • Service Providers
    • Barristers’ Sets
    • Networks
    • Interview with…
  • In-House

    • In-House Content
    • GC Powerlist
  • Knowledge Centre

    • Data Products
    • Legal Business
    • Market Intelligence
    • About us

      • Legal 500
      • FAQs
      • Marketing
      • Careers
      • Trust Centre
      • Contact us
  • Comparative Guides
  • Events
  • Legal 500 TV

About us

  • Legal 500
  • FAQs
  • Marketing
  • Careers
  • Trust Centre
  • Contact us
  • Deutschland DE
  • Paris FR
  • Rankings

    • Jurisdictions
    • Submissions
    • Future Lawyers
  • Firms & Lawyers

    • Service Providers
    • Barristers’ Sets
    • Networks
    • Interview with…
  • In-House

    • In-House Content
    • GC Powerlist
  • Knowledge Centre

    • Data Products
    • Legal Business
    • Market Intelligence
    • About us

      • Legal 500
      • FAQs
      • Marketing
      • Careers
      • Trust Centre
      • Contact us
  • Comparative Guides
  • Events
  • Legal 500 TV

About us

  • Legal 500
  • FAQs
  • Marketing
  • Careers
  • Trust Centre
  • Contact us
  • Deutschland DE
  • Paris FR

© 2026 Legalease Ltd. All rights reserved

Registered company in England & Wales No. 02427356 VAT GB 321 5727 22

Registered address: 188 Fleet Street, London, EC4A 2AG

  • Legal 500 Trust Centre
  • Contact Us
  • home
  • Market Intelligence
  • Search

332 results found

Use advanced search filters to refine your search

2 filters applied

Advanced search filters

Topics
Countries
Contributor

Start typing to add contributors

Content type
Show options
  • Article

    要想"乘风破浪"获得授权,撰写组合物权利要求需要注意这几点

    今年夏天一部热门综艺节目——《乘风破浪的姐姐》引起了广大网友们的热议,节目中30位姐姐怀揣着满腔热情实现着自己的"女团"梦。在大家兴致௡
    ChinaIntellectual Property
    Kangxin
    Kangxin
  • Article

    What Are The Contract Essentials For China-related Life Sciences Collaboration Agreements?

    China is becoming an increasing focus for transactions in the pharmaceuticals sector with its growing investment into research and development, government support and a steady...
    GlobalFood, Drugs, Healthcare, Life Sciences
    Gowling WLG
    Gowling WLG
Article

China Offers New Possibilities For Drug License Transfers

The Chinese pharmaceutical market is experiencing double-digit growth and will become the world’s second-largest market after the United States by 2016, according to IMS Health.
ChinaFood, Drugs, Healthcare, Life Sciences
Ropes & Gray LLP
Ropes & Gray LLP
  • Article

    药企如何做好海外商标布局?

    目前,跨国制药企业在全球范围内的商标注册策略相对比较完善,经验也较为丰富。本文旨在通过分享一些知名跨国制药企业的商标注册案例A
    ChinaIntellectual Property
    CCPIT Patent and Trademark Law Office
    CCPIT Patent and Trademark Law Office
  • Article

    A Legal Commentary On The Latest Implementing Regulations Of The PRC Drug Administration Law

    On January 16, 2026, the State Council of the People's Republic of China promulgated the revised Regulations for the Implementation of the Drug Administration Law (the "Implementing Regulations")...
    ChinaFood, Drugs, Healthcare, Life Sciences
    Fangda Partners
    Fangda Partners
  • Article

    China's medical device market: Trends, growth drivers and opportunities.

    China's medical device market has been rapidly developing in recent years.
    ChinaFood, Drugs, Healthcare, Life Sciences
    Acclime
    Acclime
  • Article

    Han Kun • Opinion | Quick Review Of The New Regulations: Interpret The Latest Questions And Answers Of The Ministry Of Science And Technology

    On September 8, 2023, the China Biotechnology Development Center directly under the Ministry of Science and Technology of the People's Republic of China...
    ChinaFood, Drugs, Healthcare, Life Sciences
    Han Kun Law Offices
    Han Kun Law Offices
  • Article

    Top 10 Traps To Avoid: Navigating China's HGR Applications

    Based on our experience, many projects that consider multiple factors and make separate arrangements for econo
    ChinaFood, Drugs, Healthcare, Life Sciences
    Han Kun Law Offices
    Han Kun Law Offices
  • Article

    Key Takeaways on China's Pilot Plan for Segmented Production of Biological Products

    Recently, the National Medical Products Administration (the "NMPA") issued the "Pilot Work Plan for Segmented Production of Biological Products" (the "Pilot Plan"), introducing the pilot initiative for the segmented production of biological products.
    ChinaFood, Drugs, Healthcare, Life Sciences
    Han Kun Law Offices
    Han Kun Law Offices
  • Article

    你了解药品通用名称、商品名称、药品商标之间有什么关联吗?

    药品作为一种特殊商品,承载着千百万消费者的生命健康安全。国家对于药品的监管,犹如一位严谨的编辑,严格把关每一个细节。
    ChinaFood, Drugs, Healthcare, Life Sciences
    Kangxin
    Kangxin
  • Article

    China On The Move: Fine-Tuning The Life Sciences Regulatory And Compliance Landscape

    In China, recent technological advances and legislative and regulatory developments that attempt to balance risk mitigation and innovation continue to reshape the life sciences sector in terms of cross-border...
    ChinaFood, Drugs, Healthcare, Life Sciences
    Greenberg Traurig
    Greenberg Traurig
  • Article

    汉坤 • 观点 | 中国药品年度报告制度简析

    2022年4月11日,国家药品监督管理局(" 国家药监局")发布了《药品年度报告管理规定》以及相应的报告模板(以下合称" 《年报规定》")...
    ChinaFood, Drugs, Healthcare, Life Sciences
    Han Kun Law Offices
    Han Kun Law Offices
  • Article

    The Impact Of Scientific Data Administrative Measures On Foreign Companies In China

    On March 17, 2018, the Chinese State Council passed the Scientific Data Administrative Measures (the "Measures") to standardize the management of scientific data at a national level.
    ChinaFood, Drugs, Healthcare, Life Sciences
    Ropes & Gray LLP
    Ropes & Gray LLP
  • Article

    A New Milestone In China's Regulation Of Human Genetic Resources 中国人类遗传资源监管的新里程碑

    On June 1, 2023, the Ministry of Science and Technology (MOST) issued the Implementation Rule for the Regulation on the Administration of Human Genetic Resources (the Implementation Rule)...
    ChinaFood, Drugs, Healthcare, Life Sciences
    Arnold & Porter
    Arnold & Porter
  • Article

    A New Adventure For Wholly Foreign Invested Hospital

    Wholly foreign-invested hospitals have always been a sector under relatively strict regulation in the PRC, except for limited cases as pilots.
    ChinaFood, Drugs, Healthcare, Life Sciences
    CMS
    CMS
  • Article

    Understanding China's Pharmaceutical Patent Linkage System: Framework And Case Overview (Part 1)

    The fourth amendment to the Patent Law of the People's Republic of China (hereinafter, the "Patent Law") came into effect on June 1, 2021. In July of the same year, the Measures for the Implementation...
    ChinaIntellectual Property
    Chang Tsi & Partners
    Chang Tsi & Partners
  • Article

    Overview: 2022-2023 China Drug & Medical Device Annual Report

    China's National Medical Products Administration (NMPA) released the 2023 Drug Review Annual Report on its official website on February 4, 2024...
    ChinaFood, Drugs, Healthcare, Life Sciences
    Han Kun Law Offices
    Han Kun Law Offices
  • Article

    China Pilots Lifting Restrictions On Foreign Investment In Stem Cell, Gene Therapy, And Genetic Diagnosis Sectors In Four Free Trade Zones

    On September 8, 2024, the Ministry of Commerce, together with the National Health Commission and the National Medical Products Administration (hereinafter referred to as the "Three Departments"), publicly issued the Notice on Carrying Out Pilot Programs to Expand Opening-Up in the Healthcare Sector (hereinafter referred to as the "Notice")...
    ChinaFood, Drugs, Healthcare, Life Sciences
    Han Kun Law Offices
    Han Kun Law Offices
  • Article

    Navigating The Latest Changes In China's Regulation Of Human Genetic Resources 应对中国人类遗传资源监管新的最新变化

    Multinational companies have been required to obtain pre-approval from, or complete record-filing with, the Human Genetic Resources Administration of China (HGRAC) ...
    ChinaFood, Drugs, Healthcare, Life Sciences
    Arnold & Porter
    Arnold & Porter
  • Article

    China Life Sciences: 2024 Year In Review

    The life sciences industry remained a primary focus for Chinese regulators in 2024. Key developments such as China's first draft law regulating the medical device industry, the Medical Device Administration Law (《中华人民共和国医疗器械管理法(草案征求意见稿)》),
    ChinaFood, Drugs, Healthcare, Life Sciences
    Arnold & Porter
    Arnold & Porter
  • Showing 221–240 of 332 results

    PreviousNext
    Legal Intelligence Newsletters: sign up for the latest legal and regulatory news on your chosen topics